LY4086940 History and Updates

5 events · 2025 – present

Synced daily from openFDA and ClinicalTrials.gov. Last sync: .

0
FDA Approvals
0
Label Revisions
5
Trial Milestones
0
Pivotal Publications
LY4086940 — history and updatesFDA approvals, label revisions, recalls, trials, and pivotal publicationsFDA approvalsLabel revisionsRecalls + safetyTrialsPublications202520262027Trial: NCT06945419 2025-04-23 → 2026-08-31 (primary completion)today (2026-08-24)FDA approvalLabel revisionRecall or safetyTrial activityPivotal publication

Source: openFDA, ClinicalTrials.gov via AACT, PubMed · Hipa.ai, 2026-08-24Download chart as PNG

This page tracks every FDA action, clinical trial milestone, and major publication for LY4086940 since 2025, drawn from openFDA, ClinicalTrials.gov, and PubMed.

Past events

2026
Primary completion· ClinicalTrials.gov
Phase 1 primary completion: NCT06945419
A Study of LY4086940 in Healthy Participants and Participants With Overweight or Obesity, With or Without Type 2 Diabetes
Primary completion· ClinicalTrials.gov
Phase 1 primary completion: NCT06945419
A Study of LY4086940 in Healthy Participants and Participants With Overweight or Obesity, With or Without Type 2 Diabetes
Primary completion· ClinicalTrials.gov
Phase 1 primary completion: NCT06945419
A Study of LY4086940 in Healthy Participants and Participants With Overweight or Obesity, With or Without Type 2 Diabetes
2025
Trial started· ClinicalTrials.gov
Phase 1 trial started: NCT06945419
A Study of LY4086940 in Healthy Participants and Participants With Overweight or Obesity, With or Without Type 2 Diabetes

Sources

FDA approvals, label revisions, and recalls come from the public openFDA APIs (Drugs@FDA, Drug Label, Drug Enforcement). Drug-safety communications come from the FDA RSS feed. Trial milestones come from ClinicalTrials.gov via the AACT pg dump. Pivotal-publication events come from PubMed, filtered to high-impact journals linked to a Phase 3 trial in our inventory.